# Digital Evaluations and Technologies Enabling Clinical Translation for AD

> **NCT05385913** · — · UNKNOWN · sponsor: **Oregon Health and Science University** · enrollment: 200 (estimated)

## Conditions studied

- Alzheimer Disease, Early Onset

## Interventions

- **OTHER:** Multivitamin-no intervention

## Key facts

- **NCT ID:** NCT05385913
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-12-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385913, "Digital Evaluations and Technologies Enabling Clinical Translation for AD". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05385913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*